Statistics

Total Visits

	Views
Efectividad y riesgos del tratamiento biológico con Natalizumab en esclerosis múltiple	670

File Visits

	Downloads
TFG-M-M1037.pdf	381
TFG-M-M1037-ANEXO.pdf	164

Select a period of time:

ViewsDownloads

Number of views in the range

	Views
Efectividad y riesgos del tratamiento biológico con Natalizumab en esclerosis múltiple	157

Number of downloads in the range

	Downloads
TFG-M-M1037.pdf	48
TFG-M-M1037-ANEXO.pdf	12

Views

	Views
May 2025	27
June 2025	11
July 2025	15
August 2025	13
September 2025	15
October 2025	31
November 2025	45

Download CSV file

Bar graph

Line graph

Number of downloads in the period of time

Downloads
May 2025

13
June 2025

7
July 2025

15
August 2025

3
September 2025

9
October 2025

3
November 2025

10
Download CSV file

Bar graph

Line graph

Top country views

	Views
United States	63
Spain	27
China	14
Venezuela	9
Russia	9
Belgium	8
Hong Kong	5
Ukraine	4
Brazil	3
Vietnam	3

Top countries by downloads

	Downloads
United States	16
Spain	12
China	6
Venezuela	1
Russia	1
Hong Kong	1
Brazil	1

Top cities views

	Views
Inca	8
Dallas	8
Los Angeles	7
Valladolid	6
Madrid	6
Central	5
Brussels	5
Kyiv	4
Beijing	2
San Francisco	2

Top cities by downloads

	Downloads
Los Angeles	3
Inca	2
Madrid	1
Central	1